L-glutathione Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: Vendor-neutral scientific reference catalog entry for L-glutathione

Endogenous thiol tripeptide; antioxidant and redox metabolite compound Reference needs_revision Best effort · source review pending

Also known as: Glutathione, Reduced glutathione, GSH, Glutathione-SH, gamma-L-glutamyl-L-cysteinylglycine, L-gamma-glutamyl-L-cysteinylglycine, CAS 70-18-8

Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.

Quick Facts

Reference Sizes
Not standardized / source review pending
Components
L-glutamic acid + L-cysteine + Glycine

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
L-glutamic acid
Calculator Profile
Component
L-cysteine
Calculator Profile
Component
Glycine
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Best-Effort Research Profile

L-glutathione, commonly referring to reduced glutathione (GSH), is the tripeptide L-gamma-glutamyl-L-cysteinylglycine. It is classified as a thiol, tripeptide, L-cysteine derivative, antioxidant, cofactor, and human metabolite. GSH functions in redox reactions, supports glutathione peroxidase, glutathione S-transferase, and glyoxalase systems, participates in xenobiotic conjugation, and helps maintain protein thiol homeostasis.

Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.

Research Profile

Half-Life
Intravenous human study: 14.1 ± 9.2 minutes after infusion of 2 g/m² reduced glutathione in 10 healthy volunteers. This value is route-, dose-, and study-specific and should not be generalized to oral or topical formulations.
Administration Routes (Research)
Oral: studied in human supplementation and pharmacokinetic research; exposure is formulation-dependentIntravenous: studied in human pharmacokinetic researchIntramuscular: reported as a research or clinical route in review literatureTopical: studied in dermatologic and cosmetic research

Reported Research Effects

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Notes

Neutral reference information from human studies: one pharmacokinetic study administered 2 g/m² intravenously to 10 healthy volunteers and reported a plasma elimination half-life of 14.1 ± 9.2 minutes. A review of oral supplementation literature reported human studies using 250 or 1,000 mg/day for six months, while dermatology studies have evaluated oral regimens including 250 mg once daily, 250 mg twice daily, and 500 mg once daily. These are published study regimens, not generalized dosing recommendations. Oral absorption, systemic availability, and measured effects vary by formulation and study design. No universal catalog reference size was identified as an authoritative scientific fact; commonSizes is therefore left empty.

Supplementary research context only. Not medical advice or a treatment recommendation.

Registry Identifiers

CAS RN 70-18-8; PubChem CID 124886; ChEBI CHEBI:16856; MeSH D005978; molecular formula C10H17N3O6S; average molecular mass 307.328 g/mol; InChIKey RWSXRVCMGQZWBV-WDSKDSINSA-N

Source-Backed Observations

The term L-glutathione generally denotes the reduced thiol form, while oxidized glutathione is glutathione disulfide (GSSG). Oral bioavailability and systemic exposure are formulation- and study-dependent. Following intravenous administration in a human pharmacokinetic study, exogenous glutathione was rapidly cleared and converted or redistributed into sulfur-containing metabolites.

Reflects published research. Educational reference — not a recommendation for use.

Sources Under Review

Glutathione MeSH Descriptor Data 2026
https://meshb.nlm.nih.gov/record/ui?ui=D005978 (accessed 2026-09-13)
Glutathione | CID 124886
https://pubchem.ncbi.nlm.nih.gov/compound/GLUTATHIONATE (accessed 2026-09-13)
The antioxidant glutathione
https://pubmed.ncbi.nlm.nih.gov/36707132/ (accessed 2026-09-13)
High-dose intravenous glutathione in man: Pharmacokinetics and effects on cyst(e)ine in plasma and urine
https://pubmed.ncbi.nlm.nih.gov/1907548/ (accessed 2026-09-13)
Glutathione as a pharmacological target: pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
https://pmc.ncbi.nlm.nih.gov/articles/PMC10075255/ (accessed 2026-09-13)

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention L-glutathione or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top